Administering NMT to Reestablish Infant Nasal Microbiome Diversity Following Intranasal Mupirocin Treatment

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Administering NMT to Reestablish Infant Nasal Microbiome Diversity Following Intranasal Mupirocin Treatment	Bacterial Infections and Mycoses, Disease Attributes, Infections, Pathologic Processes, Pathological Conditions, Signs and Symptoms, bacterial infectious disease, gram-positive bacterial infections, infectious disease, staphylococcal infection	Recruiting	Phase 1	2026-08-10		NCT06805994

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Johns Hopkins University	579

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Johns Hopkins University	Baltimore	United States	150

Clinical trials